"Some independent garages are having to look closely at maximising their return from their garage facility to address rising costs whilst the MOT fee has staggeringly remained frozen since 2010. This ...

A loft conversion can be a great way to add value and living space to your home, but it doesn't come cheap. To find out how much a loft conversion costs in 2025, the Building Cost Information Service ...

Retail prescription drug spending rose 11.4% to $449.7 billion, with obesity and diabetes drugs driving the increase. Private insurance spending grew 11.5% to $1.5 trillion, representing 30% of ...

It slashed expenses by about 40% to Rs 1,627 crore from Rs 2,734 crore YoY. SoftBank-backed edtech startup Unacademy’s losses narrowed significantly by 62% in the last financial year ended March 31, ...

"We just looked at diamonds and we didn't think about costs or how these particles could be mined," he said. "But obviously these are also questions that need to be considered [to determine] if it ...

According to Checkatrade, the average cost of a 30-square-metre loft conversion in the UK is around £50,000. That said, the average price can range from £27,500 to £75,000 – and more.

The IRS will “step up” the valuation on the assets to their current market value, so those valuations become the new cost basis for any subsequent capital gains assessments should those assets ...

Rachel Reeves’s inheritance tax raid on family businesses and farms will backfire by costing the Treasury over £1bn more than it makes, economists have said. A drop in investment caused by the ...

TalkTalk is to cut hundreds of jobs as the debt-laden broadband business scrambles to strip out £120m in costs. In an update to investors last week, TalkTalk outlined plans for a “radical ...

But one thing that might not put you in the festive spirit is the rising cost of living and how this might affect your ho-ho-holidays. With everything from the cost of energy bills to the average ...

Five drugs with unsupported price increases in 2023 resulted in $815 million in additional costs for U.S. payers. The flagged drugs—Biktarvy, Darzalex, Entresto, Cabometyx, and Xeljanz—lacked ...

It is part of a secret internal cost-cutting campaign that targets a growing financial burden for the company: the treatment of thousands of children with autism across the country. ProPublica has ...